Related Experiment Video
Updated: May 13, 2026

Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult
Published on: April 26, 2018
Congenital rubella syndrome in fiji, 1995-2010
Sheetalpreet Singh1, Frances Bingwor, Katherine Tayler-Smith
1Health Information Unit, Division of Health Information, Research and Analysis, Ministry of Health, Government Buildings, P.O. Box 2223, Suva, Fiji.
Insights
Reports of congenital rubella syndrome (CRS) are increasing in Fiji, despite no clear link to rubella incidence. Enhanced surveillance and rubella vaccination are crucial for public health.
Area of Science:
- Public Health
- Epidemiology
- Pediatrics
Background:
- Congenital rubella syndrome (CRS) is a preventable consequence of maternal rubella infection during pregnancy.
- Effective rubella vaccination programs are essential for preventing CRS outbreaks.
- Surveillance systems are critical for monitoring disease trends and informing public health interventions.
Purpose of the Study:
- To determine the incidence of congenital rubella syndrome (CRS) in Fiji between 1995 and 2010.
- To investigate the relationship between CRS incidence and notified rubella cases over the 16-year study period.
- To identify trends in CRS reporting and inform public health strategies in Fiji.
Main Methods:
- A descriptive, retrospective review was conducted on recorded congenital abnormalities in live births across Fiji.
- Data spanned a 16-year period, from 1995 to 2010.
- Infants meeting CRS criteria were identified and classified based on diagnostic confirmation levels.
Main Results:
- A total of 294 infants met the criteria for suspected or confirmed CRS.
- The incidence of reported CRS cases showed a significant linear increase annually (OR 1.045 per year).
- No significant association was found between the incidence of CRS and reported rubella cases (P = 0.3).
Conclusions:
- There is an upward trend in suspected congenital rubella syndrome (CRS) cases reported in Fiji.
- Improved clinical and laboratory diagnostic capabilities are needed to accurately confirm or exclude CRS cases.
- Strengthening rubella vaccination coverage is vital to mitigate the risk of CRS in Fiji.
Abstract:
Setting. A nationwide study in Fiji. Objective. To describe the incidence of congenital rubella syndrome (CRS) and its relationship to the incidence of notified cases of rubella in Fiji from 1995 to 2010. Design. Descriptive, retrospective review of all recorded congenital abnormalities associated with live births in Fiji over 16 years. Results. There were 294 infants who met the criteria for CRS. Of these, 95% were classified as "suspected" cases, 5% were "clinically confirmed," and none were "laboratory confirmed cases". There was a significant linear increase over the study period in the incidence of CRS (odds ratio 1.045 per year, 95% CI 1.019 to 1.071, P ≤ 0.001). There was no significant association between the incidence of CRS and the reported incidence of rubella (P = 0.3). Conclusion. There is a rising trend in reports of suspected CRS cases in Fiji. This highlights the need to strengthen surveillance for CRS through improvements in clinical and laboratory diagnosis to confirm or exclude suspected cases. It is also important to ensure high coverage of rubella vaccination in Fiji.
Related Concept Videos
Infectious Diseases and Their Occurrence
Teratogenicity
Cytomegalovirus Disease
Principles of Disease Surveillance
Diphtheria
Arboviral Encephalitis
